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1. Menopause as a natural process
Menopause is a natural and inevitable period of ageing in women that is well known to rep‐
resent the end of reproductive life through the failure of ovarian function, accompanied by 
a decrease in estrogen and progestin production in the periphery and brain [1, 2]. Sexual 
hormones, such as estradiol and progesterone, help regulate metabolic function and interact 
with a wide range of neurotransmitters, such as serotonin, dopamine, λ‐aminobutyric acid, 
and glutamate, among others [3]. Lower concentrations of these hormones during menopause 
have been associated with the development of specific diseases. Hormonal changes during 
menopause are also involved in sex differences in brain disorders that develop in aged indi‐
viduals. The United States National Institutes of Health established a research priority to 
encourage investigations of the impact of gender on normal brain function and central ner‐
vous system‐related diseases [4]. Studying menopause from a multidisciplinary perspective 
will help unveil different factors that affect health in this specific stage of life in women.
During menopause, lower hormone production is related to a higher incidence of vasomotor 
symptoms, such as hot flashes, vaginal dryness, osteoporosis, cognitive deterioration, irrita‐
bility, anxiety, and mood disorders (e.g., depression) [5–8]. Menopause can occur gradually 
as a natural ageing process, culminating around age 50 years, or it can occur suddenly after 
surgical procedures, such as oophorectomy, salpingo‐oophorectomny, and hysterectomy [9]. 
When menopause is caused by surgical manipulations, the negative symptoms can be more 
severe than when it occurs naturally [10]. Changes that occur during menopause interact with 
genetic, nutritional, sociocultural, and demographic factors [11, 12], differentially impacting 
quality of life in menopausal women. Research on menopause requires considerations of biol‐
ogy, physiology, sociology, and psychology to achieve better knowledge of this physiological 
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state in women and design the therapeutic approaches that focus on pharmacological treat‐
ment and psychological and physical therapy.
2. A multidisciplinary look at menopause
In this book, Dr. Kirchengast (Chapter 2) approaches menopause as a normal female stage 
that is a product of the overall ontogenetic and phylogenetic development of Homo sapiens, 
with a focus on evolutionary anthropology. This chapter is complemented by the work of Dr. 
Rovirosa‐Hernández and collaborators (Chapter 3) that details the physiological changes that 
occur at the end of the reproductive life cycle in nonhuman primates. They compare these 
changes with those that are observed in menopausal women to gain a better understanding 
of human menopause.
Dr. Afridi Iqbal (Chapter 4) describes the ways in which psychological factors impact self‐
concepts and the mental health of women who experience menopause and the ways in which 
these factors can trigger variations in mood and such disorders as anxiety and depression.
Dr. García‐Ríos and collaborators (Chapter 5) discuss the changes in serotonergic neurotrans‐
mission associated with changes in the concentrations of steroid hormones in the brain that 
accompany menopause and are related to greater vulnerability to depression and a lower 
response to antidepressant therapy in depressed menopausal women. These data are relevant 
when considering that aged women respond differently to antidepressants compared with 
young women, which could be related to lower levels of steroid hormones that negatively 
impact neurotransmitter function. Preclinical studies have shown that antidepressant drug 
treatment in middle‐age ovariectomized rats that have a long‐term absence of ovarian hor‐
mones is devoid of antidepressant‐like effects, but if they are combined with estrogens, then 
an antidepressant‐like effect is detected [13].
Menopause is not considered a disease but rather a natural stage of female development. 
However, menopause is sometimes associated with several illnesses that are associated with 
physical, physiological, and psychosocial factors. The most widely used treatment for meno‐
pause‐related changes is hormone replacement therapy with estrogen, progestin, and their 
derivatives [14, 15]. Hormone replacement therapy has been shown to reduce such symptoms 
as bone loss, hot flashes, irritability, and mood swings [16, 17] and improve overall mental 
health [7]. Nevertheless, hormone replacement therapy also has side effects that restrict its 
long‐term use in some women [18, 19]. Consequently, medicinal alternatives are needed to 
ameliorate menopause symptoms with a lower risk of severe side effects. Therapeutic alter‐
natives mainly consist of dietary supplements that contain natural compounds, such as phy‐
toestrogens, including isoflavones, flavones, lignans, coumestans, and stilbenes. Preclinical 
studies have shown that the phytoestrogen genistein reverses anxiety‐like behavior in an 
experimental model of surgical menopause [20] and depression‐like behavior [21].
Dr. Estrada‐Camarena and collaborators (Chapter 6) describe in detail the effects of nonste‐
roid hormone therapy that is based on the use of natural and synthetic phytoestrogens. They 
A Multidisciplinary Look at Menopause2
present preclinical and clinical evidence of the ways in which phytoestrogens interact with 
specific receptors in the brain to reduce anxiety and depression symptoms and ameliorate 
other illnesses that are associated with menopause.
Dr. Bittar Simoni (Chapter 7) describes the positive effects of physical activity on health in 
menopausal women. In his chapter, he discusses the ways in which different exercise regimens 
can improve body composition, functional performance, strength, and balance, thus positively 
impacting physical health and emotional and affective states. For example, a positive interaction 
has been found between estradiol concentrations and physical activity that attenuates endo‐
crine responses to stress [22], thus decreasing irritability, anxiety, and depression symptoms.
3. Concluding remarks
Menopause is characterized by physiological, biological, and psychosocial changes that 
impact lifestyle and predispose them to the development of different diseases. The current 
therapeutic approaches are diverse, including drugs, hormones, chemical products of natural 
origin, meditation, and exercise, each of which have specific risks and benefits. Unfortunately, 
because of the complexity of the physiological and psychological changes that are associ‐
ated with menopause, no completely safe and effective treatment for all symptoms has been 
developed.
Genetic differences can also influence the severity of symptoms and response to conventional 
therapies [11, 23], thus complicating the development of a general therapeutic approach for 
all menopausal woman. Understanding the causes of diseases that are associated with meno‐
pause and responses to different treatments should utilize a multidisciplinary approach to 
achieve combined therapeutic strategies for specific groups of menopausal women. Decisions 
regarding the treatment for menopausal women should consider symptomatology, health 
status, immediate and long‐term health risk, personal life expectations, and the availability 
and cost of therapy [2]. Safer and more effective therapeutic alternatives for the management 
of menopausal symptoms need to be developed, specifically for women who present contra‐
indications to hormone therapy. Although great advances have been made from psychologi‐
cal, physiological, pharmacological, and environmental perspectives, still much work needs 
to be done.
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